Article Details
Retrieved on: 2024-02-19 01:12:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
SHANGHAI, Feb. 19, 2024 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a biotechnology company dedicated to developing and commercializing ...
Article found on: en.prnasia.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here